, Tracking Stock Market Picks
Enter Symbol:
Amylin Pharmaceuticals, Inc. (AMLN) [hlAlert]

down 65.64 %

Amylin Pharmaceuticals, Inc. (AMLN) downgraded to Sell by Canaccord Adams

Posted on: Wednesday,  Jan 28, 2009  8:25 AM ET by Canaccord Adams

Canaccord Adams rated Sell Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) on 01/28/2009, when the stock price was $10.63. Since
then, Amylin Pharmaceuticals, Inc. has gained 191.06% as of 08/06/2012's recent price of $30.94.
If you would have followed this Canaccord Adams's recommendation on AMLN, you would have lost 65.64% of your investment in 1286 days.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over one thousand five hundred employees nationwide.

Canaccord Adams provides focused, actionable, idea-driven research, helping clients make informed investment decisions. Our 55 international analysts scour the globe for emerging and small to mid cap (US$1-2 billion market capitalization) growth opportunities, identifying value and exposing risk. Our research team analyzes over 550 companies in eight sectors, clarifying current events and anticipating market trends in high-quality daily, weekly and monthly research products. Our clients benefit from our thorough and sophisticated knowledge of the sectors we cover - Metals and Mining, Energy, Technology, Life Sciences, Real Estate, Consumer, Sustainability and Industrial Growth. We combine independent, actionable ideas, unique global perspective and unparalleled industry expertise. We believe it's evident in our research, and the foundation of our business.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2009 8:25 AM Sell
as of 12/31/2009
1 Week down  -5.32 %
1 Month down  -5.39 %
3 Months down  -9.78 %
1 YTD down  -41.39 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2008 8:25 AM Hold
2/12/2008 9:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy